You are here: Industry Insights > eczema

News List

Atopic dermatitis market set to almost triple in value over next 10 years pharmafile
December 13, 2018
The atopic dermatitis (eczema) market is expected to reach $18.3 billion by 2027, according to analytics firm GlobalData.
1 in 10 Will Develop Eczema in Their Lifetime drugs
December 04, 2018
About 10 percent of people will suffer from the itchy skin condition known as eczema at some point in their lives, new research shows......
Realm surrenders after back-to-back clinical defeats fiercebiotech
September 18, 2018
Faced with a pair of phase 2 failures, Realm Therapeutics has abandoned the platform that underlies all its drug development programs and engaged advisers to look into a possible sale...
Zai Lab cans ex-GlaxoSmithKline eczema drug after phase 2 flop fiercebiotech
August 27, 2018
Zai Lab has stopped development of a treatment for atopic dermatitis after it failed to beat placebo in a phase 2a trial.
Eczema drug effective against severe asthma worldpharmanews
June 05, 2018
Two new studies of patients with difficult-to-control asthma show that the eczema drug dupilumab alleviates asthma symptoms and improves patients' ability to breathe better than standard therapies.
Bacteria therapy shows promise for eczema europeanpharmaceuticalreview
May 09, 2018
Topical treatment with live Roseomonas mucosa was found to be safe for adults and children with atopic dermatitis…
New treatments help those with mild, moderate and severe eczema europeanpharmaceuticalreview
October 30, 2017
Crisaborole and dupilumab approved for atopic dermatitis…
LEO Pharma announces positive results from phase 2b clinical study for Tralokinumab in Atopic Dermat pharmaasia
March 16, 2017
LEO Pharma announced positive results from a Phase 2b dose-ranging efficacy and safety study of tralokinumab in adult patients.

Previous page 1 2 Next page